Business

Drugs Made In America Acquisition II Prices $500 Million IPO

Drugs Made In America Acquisition II Prices $500 Million IPO

Latest Headlines

Top Stories

Breaking News

Stock Alerts

Wallstreet Events

Industry News

Industry News

Corp. Calendars

Stock Splits

Conference Calls

Earnings Calendar

Earnings Calendar

Pos Pre-announcements

Profit Warnings

Positive Surprise

Negative Surprise

Latest Earnings

FDA Calendars

Drug Approvals

Clinical Trial Calendar

Ratings Changes

Cov Initiations

Cov. Reiterated

Economic News

Economic Calendar

Economic Scorecard

Cryptocurrency

Cryptocurrency

Morning Mkt Analysis

US Commentary

European Commentary

Asian Commentary

Canadian Commentary

Indian Commentary

Commodities

White House

General News

FX Top Stories

Currency Analysis

Currency Alerts

Economic Calendar

Economic Scorecard

Coronavirus

COVID-19 Calendar

Diet & Fitness

Kids Health

Men’s Health

Women’s Health

Cancer News

Drug Development

Mental Health

Slide Shows

Entertainment

Entertainment

Top Stories

Classic Rock

Rap/Hip-Hop

Alternative

Content Licensing

Content Licensing

Newswires & Feeds

Content Syndication

Digital Signage Services

Radio News Services

Premium Services

Intelligent Investor

Biotech Investor NEW

Latest News Videos

Free Content

Press Releases

Latest Headlines

Stock Alerts

Top Stories

Breaking News

Wallstreet Events

Industry News

Corp. Calendars

Stock Splits

Conference Calls

Earnings Calendar

Earnings Calendar

Pos Pre-announcements

Profit Warnings

Positive Surprise

Negative Surprise

Latest Earnings

FDA Calendars

Drug Approvals

Clinical Trial Calendar
Ratings Changes

Cov Initiations

Cov. Reiterated

Economic Calendar

Economic Scorecard

Cryptocurrency

Market News

Morning Mkt Analysis

US Commentary

European Commentary

Asian Commentary

Canadian Commentary

Indian Commentary

Commodities

White House

General News

FX Top Stories

Currency Analysis

Currency Alerts

Economic Calendar

Economic Scorecard

Health News

Coronavirus

COVID-19 Calendar

Diet & Fitness

Kids Health

Men’s Health

Women’s Health

Cancer News

Drug Development

Mental Health

Slide Shows

Entertainment

Entertainment News

Top Stories

Classic Rock

Rap/Hip-Hop

Alternative

Content Licensing

Newswires & Feeds

Content Syndication

Digital Signage Services

Radio News Services

Intelligent Investor

Biotech Investor

Latest News Videos

Free Content

Press Releases

Quick Facts

Drugs Made In America Acquisition II Prices $500 Million IPO

By RTTNews Staff Writer ✉
| Published: 9/25/2025 7:11 AM ET

Drugs Made In America Acquisition II Corp. (DMIIU), a blank check company, on Thursday announced the pricing of its initial public offering of 50 million units at $10.00 per unit, raising $500 million.
The underwriters have been granted a 45-day option to purchase up to an additional 7.5 million units. The units are expected to begin trading on the Nasdaq Global Market on September 25, under the ticker symbol DMIIU.
Each unit consists of one share plus the right to receive 1/10th of a share upon completion of an initial business combination. Once the securities begin separate trading, the ordinary shares and rights are expected to trade on Nasdaq under the symbols DMII and DMIIR, respectively.

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering, which is expected to close on September 26, 2025.
For comments and feedback contact: editorial@rttnews.com
Business News

Slide Shows

Biotech Stocks Facing FDA Decision In September 2025

Biotech Stocks Facing FDA Decision in April 2025

Biotech Stocks Facing FDA Decision In March 2025

Global Economics Weekly Update – August 25 – 29, 2025

August 29, 2025 14:37 ET
Revised second quarter economic growth data from the U.S. was among the main economic news this week. Survey data reflecting consumer perceptions were also in focus. In Europe, survey results for the private sector economy as well as a key business confidence survey from the biggest euro area economy drew attention. News flow in Asia was dominated by the Bank of Korea that announced its latest policy decision and gave its view on the recent trade tariff situation.

View More Videos

RELATED NEWS

Drugs Made In America Acquisition II Prices $500 Million IPO

Latest Updates on COVID-19

HHS Convenes Patient Roundtables In Fight Against Long COVID
September 19, 2025 10:25 ET

Poll Finds 1 In 6 Parents Skipping Childhood Vaccines Beyond COVID And Flu
September 16, 2025 18:05 ET

Most Emailed

Walmart To Kick Off Holiday Season With Early Deals On Oct. 7-12
September 23, 2025 05:20 ET

China’s BYD Stock Down On Reports Of Warren Buffett’s Berkshire Hathaway Sells Out Stake
September 22, 2025 07:54 ET

AstraZeneca: CHMP Recommends Approval Of Tezspire In The EU
September 22, 2025 02:19 ET

Kirkland Signature Ahi Tuna Wasabi Poke Sold At Costco Recalled
September 22, 2025 08:26 ET

Patient Square Capital Affiliate To Acquire Premier Inc.
September 22, 2025 06:42 ET

Ionis Pharma Reports Positive Topline Results From Pivotal Study Of Zilganersen In Alexander Disease
September 22, 2025 07:36 ET

LANXESS To Exercise Right To Offer To Sell Its Shares In Envalior In 2026
September 23, 2025 08:45 ET

Compass And Anywhere Real Estate To Combine In $10 Bln All-Stock Merger Deal
September 22, 2025 08:04 ET

Stellantis Halts Production In France And Italy Due To Weak Demand
September 23, 2025 11:58 ET

Axon To Acquire AI Powered Emergency Communications Platform Prepared
September 23, 2025 11:51 ET

RideCo: Via’s Damages Claim Cut By More Than 85%; Confident In Legal Positions On Appeal
September 22, 2025 09:17 ET

Sempra To Sell 45% Equity Interest In Sempra Infrastructure Partners For $10 Bln Cash
September 23, 2025 08:27 ET

Ascletis Pharma’s ASC47 + Semaglutide Combo Cuts Obesity By 56%
September 21, 2025 21:01 ET

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
September 22, 2025 01:12 ET

Faraday Future Invests $41 Mln In Qualigen To Power Crypto Expansion Across Three Growth Engines
September 21, 2025 21:27 ET

Gurit Holding Names Viktor Bernhardt As CFO
September 22, 2025 01:20 ET

Yokogawa And Toyota Partner On Lunar Rover Tech Ahead Of 2031 Mission
September 21, 2025 22:30 ET

FDA Approves IND For Nanjing Leads Biolabs’ LBL-047, Bispecific Targeting BDCA2 And TACI
September 22, 2025 01:26 ET

Iberdrola To Supply Clean Electricity To Amazon In Oregon By Investing $100 Mln
September 23, 2025 06:19 ET

Genentech Reports Positive Results From Phase III EvERA Study
September 22, 2025 01:31 ET

Onsemi To Acquire Rights To Vcore Power Technologies From Aura Semiconductor
September 23, 2025 06:20 ET

Idorsia: Simcere To Introduce QUVIVIQ To Patients In China
September 22, 2025 01:43 ET

Elanco Gets FDA Nod For Updated Zenrelia Label, Removes Vaccine-Induced Disease Warning
September 23, 2025 06:55 ET

Ipsen Reports Positive Phase II Data For IPN10200 In Glabellar Lines, Shows Long-Lasting Efficacy
September 22, 2025 01:43 ET

Editors Pick

Starbucks To Close Coffeehouses, Cut 900 Jobs In $1 Bln Restructuring
September 25, 2025 09:45 ET

Walmart To Kick Off Holiday Season With Early Deals On Oct. 7-12
September 23, 2025 05:20 ET

Kirkland Signature Ahi Tuna Wasabi Poke Sold At Costco Recalled
September 22, 2025 08:26 ET

China’s BYD Stock Down On Reports Of Warren Buffett’s Berkshire Hathaway Sells Out Stake
September 22, 2025 07:54 ET

Copyright © 2025 RTTNews. All rights reserved.By using this site, you agree to the
Terms of Service.
About Us |
Contact Us